Multidomain cognitive impairment, along with comorbidities and psychiatric hospitalizations, shorten survival time of patients with Alzheimer's disease dementia: A long term, naturalistic follow-up study
Open Access
- 11 July 2026
- journal article
- research article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 113 (1) , 291-301
Abstract
Background: The survival time following an initial Alzheimer's disease dementia (ADD) diagnosis is influenced by various demographic, cognitive and clinical factors. Cognitive clusters are more detailed than individual cognitive measures, but they are rarely used as predictors in survival analyses. Objective: We conducted a long-term retrospective study following patients from the time of their initial ADD diagnosis until their death. Cognitive clusters as well as clinical data were assessed as predictors of survival time. Methods: We used hierarchical clustering to identify cognitive clusters based on the results of neuropsychological examinations (CERAD-Plus). We fitted a Cox regression model with cognitive clusters and clinical covariates (e.g., age, sex, Mini-Mental State Examination [MMSE] score, annual rate of hospitalizations, and pre-existing diseases) to predict survival time. Results: Data from 202 patients (mean age = 77.79 ± 5.35 years; mean survival time 74.04 ± 41.03 months) were analyzed. Two cognitive clusters were identified: the amnestic cluster (AC, N = 89) and the mixed cluster (MC, N = 80). The Cox regression models identified the following variables as most predictive of shorter survival times: higher age (HR = 1.04) and lower MMSE score at baseline (HR = 0.92), pre-diagnosed atrial fibrillation (HR = 2.06) and delirium (HR = 3.13), and a higher annual rate of psychiatric (HR = 4.84) and somatic (HR = 1.67) hospitalizations. Patients in the MC had a shorter survival time than those in the AC group (HR = 1.45). Conclusions: This study provides evidence that a detailed analysis of neuropsychological profiles at the time of ADD diagnosis can predict disease progression. Preventing psychiatric hospitalizations, especially, could positively influence the survival of ADD patients.Keywords
Funding Information
- Austrian Alzheimer´s Association
- Dr. Johannes und Hertha Tuba-Foundation
This publication has 40 references indexed in Scilit:
- Biological sex matters in brain agingNeuron, 2025
- Survival After the Diagnosis of Mild‐to‐Moderate Alzheimer's Disease Dementia: A 15‐Year National Cohort Study in TaiwanInternational Journal of Geriatric Psychiatry, 2024
- Economic Status and Mortality in Patients with Alzheimer's Disease in Japan: The Longevity Improvement and Fair Evidence StudyJournal of the American Medical Directors Association, 2022
- New insights into atypical Alzheimer's disease in the era of biomarkersThe Lancet Neurology, 2021
- Risk factors for in-hospital mortality in patients with dementiaMaturitas, 2019
- Clinical validity of delayed recall tests as a gateway biomarker for Alzheimer's disease in the context of a structured 5-phase development frameworkNeurobiology of Aging, 2017
- Outcomes of dementia: Systematic review and meta-analysis of hospital administrative database studiesArchives of Gerontology and Geriatrics, 2016
- Survival in dementia and predictors of mortality: a reviewInternational Journal of Geriatric Psychiatry, 2013
- Development and validation of a geriatric depression screening scale: A preliminary reportJournal of Psychiatric Research, 1982
- “Mini-mental state”Journal of Psychiatric Research, 1975